Coen D A Stehouwer Selected Research

HDL Cholesterol

1/2023	Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies.
7/2021	The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.
1/2020	Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.
1/2020	High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.
1/2019	Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
2/2017	Estimated GFR, Albuminuria, and Cognitive Performance: The Maastricht Study.
10/2016	A Common Gene Variant in Glucokinase Regulatory Protein Interacts With Glucose Metabolism on Diabetic Dyslipidemia: the Combined CODAM and Hoorn Studies.
1/2016	Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.
5/2015	Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
10/2012	C-reactive protein, fibrinogen, and cardiovascular disease prediction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Coen D A Stehouwer Research Topics

Disease

129	Type 2 Diabetes Mellitus (MODY) 01/2024 - 02/2002
79	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2002
64	Inflammation (Inflammations) 01/2023 - 03/2002
55	Insulin Resistance 12/2023 - 02/2002
31	Obesity 01/2024 - 03/2002
30	Hypertension (High Blood Pressure) 01/2023 - 04/2002
30	Atherosclerosis 01/2023 - 03/2002
29	Prediabetic State (Prediabetes) 11/2023 - 09/2009
24	Albuminuria 01/2022 - 10/2002
18	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2005
17	Hyperglycemia 01/2023 - 08/2002
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 10/2002
14	Hyperemia 10/2022 - 05/2002
13	Non-alcoholic Fatty Liver Disease 11/2023 - 04/2007
11	Glucose Intolerance 01/2023 - 07/2002
10	Chronic Renal Insufficiency 01/2019 - 01/2007
9	Weight Loss (Weight Reduction) 12/2023 - 01/2018
8	Necrosis 04/2012 - 12/2003
8	Vascular Diseases (Vascular Disease) 04/2010 - 05/2003
7	Overweight 01/2023 - 11/2014
7	Body Weight (Weight, Body) 01/2022 - 12/2002
7	Renal Insufficiency (Renal Failure) 05/2020 - 11/2003
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 05/2002
7	Birth Weight (Birth Weights) 03/2015 - 12/2002
7	Chronic Kidney Failure (Chronic Renal Failure) 03/2009 - 09/2002
6	Dementia (Dementias) 08/2023 - 01/2015
6	Diabetes Mellitus 01/2021 - 05/2002
6	Stroke (Strokes) 01/2018 - 05/2006
6	Hyperinsulinism (Hyperinsulinemia) 08/2010 - 05/2002
5	Diabetes Complications 01/2023 - 03/2011
5	Weight Gain 03/2022 - 12/2002
5	Abdominal Obesity 01/2022 - 05/2009
5	Coronary Disease (Coronary Heart Disease) 01/2018 - 09/2003
5	Myocardial Infarction 01/2018 - 05/2006
5	Hyperhomocysteinemia 12/2011 - 09/2002
4	Fatty Liver 03/2023 - 10/2007
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 08/2002
4	Cerebral Small Vessel Diseases 01/2020 - 01/2017
4	Diabetic Angiopathies (Diabetic Angiopathy) 01/2020 - 05/2002

Drug/Important Bio-Agent (IBA)

121	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 04/2002
48	Insulin (Novolin)FDA Link 01/2024 - 03/2002
44	Biomarkers (Surrogate Marker)IBA 08/2023 - 11/2005
34	LipidsIBA 12/2023 - 08/2002
25	Retinaldehyde (Retinal)IBA 08/2023 - 04/2008
25	Advanced Glycation End ProductsIBA 01/2023 - 03/2004
24	C-Reactive ProteinIBA 12/2022 - 04/2002
23	HomocysteineIBA 10/2012 - 02/2002
20	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2002
18	HDL CholesterolIBA 01/2023 - 04/2002
18	CholesterolIBA 04/2022 - 10/2002
17	Metformin (Glucophage)FDA LinkGeneric 11/2023 - 12/2002
15	Pyruvaldehyde (Methylglyoxal)IBA 01/2023 - 04/2008
13	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 04/2007
13	SelectinsIBA 10/2022 - 03/2004
12	von Willebrand FactorIBA 01/2022 - 04/2002
11	AlbuminsIBA 01/2018 - 04/2002
11	Immunoglobulin M (IgM)IBA 01/2016 - 08/2002
10	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2023 - 03/2004
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2003
10	CreatinineIBA 01/2018 - 04/2002
9	LDL CholesterolIBA 07/2021 - 10/2002
9	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2015 - 04/2002
8	FructoseIBA 11/2023 - 04/2017
8	Complement System Proteins (Complement)IBA 01/2023 - 12/2012
8	E-SelectinIBA 01/2022 - 03/2004
8	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 05/2008
8	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 09/2002
8	EnzymesIBA 01/2019 - 12/2003
8	AdiponectinIBA 11/2018 - 06/2003
8	AdipokinesIBA 07/2014 - 05/2005
7	pentosidineIBA 10/2021 - 03/2009
7	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2015 - 05/2002
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2010 - 05/2002
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2006
6	Blood Glucose (Blood Sugar)IBA 01/2022 - 05/2012
6	Uric Acid (Urate)IBA 01/2018 - 11/2014
6	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2015 - 02/2011
6	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2015 - 05/2002
5	SodiumIBA 11/2023 - 11/2014
5	Methionine (L-Methionine)FDA Link 03/2023 - 08/2004
5	Complement C3 (C3 Complement)IBA 01/2022 - 04/2011
5	Vitamin D FDA LinkGeneric 12/2020 - 11/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 02/2006
5	Interleukin-8 (Interleukin 8)IBA 03/2015 - 03/2012
5	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 07/2012 - 09/2003
5	Plasminogen Activator Inhibitor 1IBA 03/2012 - 06/2005
4	Syntex adjuvant formulationIBA 11/2023 - 01/2017
4	Alanine Transaminase (SGPT)IBA 01/2023 - 04/2007
4	3-deoxyglucosoneIBA 01/2023 - 03/2011
4	Glyoxal (Ethanedial)IBA 01/2023 - 01/2020
4	Complement Factor D (Factor D)IBA 01/2023 - 12/2018
4	SaltsIBA 10/2022 - 09/2007
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021 - 02/2003
4	Cystatin CIBA 01/2018 - 01/2015
4	ThrombomodulinIBA 03/2015 - 03/2004
4	Receptor for Advanced Glycation End ProductsIBA 06/2014 - 04/2008
4	Fibrinogen (Factor I)FDA Link 10/2013 - 01/2005

Therapy/Procedure

20	Therapeutics 01/2023 - 12/2002
11	Glycemic Control 12/2023 - 12/2002
4	Lasers (Laser) 10/2022 - 07/2007